FDA inspection
Procter & Gamble Manufacturing Mexico, S. de R.L. de C.V.: FDA inspection ending Jun 27, 2025
FDA inspection 1275297 · Voluntary Action Indicated (VAI) · Naucalpan
Key facts
| Inspection ID | 1275297 |
|---|---|
| Firm | Procter & Gamble Manufacturing Mexico, S. de R.L. de C.V. |
| FEI number | 3002744909 |
| Address | San Andres Atoto No. 326, Colonia San Francisco Cuautlalpan |
| City | Naucalpan |
| Country | Mexico |
| Fiscal year | 2025 |
| Inspection end date | Jun 27, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data